Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Autologous and Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome: A Large Series from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Blood (2019) 134 (Supplement_1): 2053.

https://doi.org/10.1182/blood-2019-129949

Published: 2019

Journal Articles

Cord Blood Transplantation after Non Myeloablative Conditioning (Minneapolis Protocol): Impact on Transplant Outcomes in 112 Adults with Hematologic Malignancy. A French Multicentric Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and Eurocord.

Blood (2007) 110 (11): 2029.

https://doi.org/10.1182/blood.V110.11.2029.2029

Published: 2007

Journal Articles

Donor Response to G-CSF Is the Best Predictive Factor of Extensive Chronic Graft-Versus-Host Disease after Non Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation.

N. Dhedin, MD, T. Prebet, MD, D. Rea, MD, PHD, M.L. Tanguy, M. Kuentz, MD, N. Piard, MD, F. Norol, MD, PHD, J.P. Jouet, MD, Ja Rubeil, MD, R. Tabrizi, MD, B. Rio, MD, B. Lioure, MD, P. Tiberghien, MD, PHD, J.H. Bourrhis, MD, A. Sirvent, MD, P. Bordigoni, MD, D. Blaise, MD, Mauricette Michallet, MD, PHD, J.P. Vernant, MD

Blood (2007) 110 (11): 2188.

https://doi.org/10.1182/blood.V110.11.2188.2188

Published: 2007

Journal Articles

Allogeneic Stem Cell Transplantation (SCT) with Non Myeloablative Conditioning Regimen (NST) Following Intensive Consolidation May Be Equivalent to Conventional alloSCT and Superior to autoSCT for Patients over 50 with Acute Myeloid Leukemia (AML) in 1 st CR: First Results of the AML 2001 Trial.

B. Lioure, J. Delaunay, D. Blaise, N. Milpied, P. Guardiola, J.Y. Cahn, B. Witz, E. Jourdan, L. Legros, E. Randriamalala, M. Ojeda, C. Himberlin, Michel Attal

Blood (2006) 108 (11): 319.

https://doi.org/10.1182/blood.V108.11.319.319

Published: 2006

Journal Articles

Fludarabine-Based HLA-Identical Sibling HSCT for Patients with Severe Aplastic Anemia (SAA) Older Than 30 Years: A Study from the French (SFGM-TC) and Italian (GITMO) Registries.

S. Maury, B. Bruno, Z. Chir, F. Garban, D. Blaise, N. Contentin, H. Esperou, C. Cordonnier, A. Bacigalupo

Blood (2005) 106 (11): 2028.

https://doi.org/10.1182/blood.V106.11.2028.2028

Published: 2005

Journal Articles

Stem Cell Transplantation in 281 Patients over 60 Years in Onco Hematologic Malignancies: A Single Center Experience.

Anne-Marie Stoppa, MD, N. Vey, MD, C. Faucher, MD, R. Bouabdallah, MD, F. Viret, MD, C. Chabannon, MDPhD, P. Ladaique, MD, D. Coso, MD, A. Charbonnier, MDPhD, J.M. Schiano, MD, P. Viens, MD, J.A. Gastaut, MD, D. Maraninchi, MD, D. Blaise, MD

Blood (2004) 104 (11): 5229.

https://doi.org/10.1182/blood.V104.11.5229.5229

Published: 2004

Journal Articles

Long Term Infectious Complications Following Reduced Intensity Conditioning (RIC)Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

A. Etienne, M. Mohty, C. Faucher, M. Ferrando, R. Benramdane, C. Zandotti, L. Collet, N. Vey, A.M. Stoppa, D. Coso, P. Viens, J.A. Gastaut, D. Blaise

Blood (2004) 104 (11): 1234.

https://doi.org/10.1182/blood.V104.11.1234.1234

Published: 2004

Journal Articles

Fludarabine and Busulfan-Based Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Transplantation (allo-SCT) with or without Anti-Thymocyte Globulin (ATG): Comparison between Two Prospective Studies in Patients with Myeloid Malignancies.

Mohamad Mohty, R. Martino, C. Faucher, J.A. Perez-Simon, N. Vey, M.D. Caballero, J.A. Gastaut, J. San Miguel, D. Blaise, J. Sierra

Blood (2004) 104 (11): 1241.

https://doi.org/10.1182/blood.V104.11.1241.1241

Published: 2004

Journal Articles

Karyotype in Acute Myeloblastic Leukemia: Prognostic Significance for Bone Marrow Transplantation in First Remission: A European Group for Blood and Marrow Transplantation Study

A. Ferrant, M. Labopin, F. Frassoni, H.G. Prentice, J.Y. Cahn, D. Blaise, J. Reiffers, G. Visani, M.A. Sanz, M.A. Boogaerts, B. Löwenberg, N.C. Gorin

Blood (1997) 90 (8): 2931–2938.

https://doi.org/10.1182/blood.V90.8.2931

Published: 1997

Journal Articles

Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group

M Attal, D Blaise, G Marit, C Payen, M Michallet, JP Vernant, C Sauvage, X Troussard, G Nedellec, J Pico

Blood (1995) 86 (4): 1619–1628.

https://doi.org/10.1182/blood.V86.4.1619.bloodjournal8641619

Published: 1995

Journal Articles

Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)

A Devergie, D Blaise, M Attal, JD Tigaud, JP Jouet, JP Vernant, P Bordigoni, N Ifrah, C Dauriac, JY Cahn

Blood (1995) 85 (8): 2263–2268.

https://doi.org/10.1182/blood.V85.8.2263.bloodjournal8582263

Published: 1995

Journal Articles

Reconstitution of human immunoglobulin VH repertoire after bone marrow transplantation mimics B-cell ontogeny

F Fumoux, V Guigou, D Blaise, D Maraninchi, M Fougereau, C Schiff

Blood (1993) 81 (11): 3153–3157.

https://doi.org/10.1182/blood.V81.11.3153.3153

Published: 1993

Journal Articles

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

D Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergie, JP Jouet, N Milpied, M Attal, M Michallet, N Ifrah

Blood (1992) 79 (10): 2578–2582.

https://doi.org/10.1182/blood.V79.10.2578.2578

Published: 1992

Journal Articles

Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia

MF Bertheas, M Lafage, P Levy, D Blaise, AM Stoppa, P Viens, P Mannoni, D Maraninchi

Blood (1991) 78 (11): 3103–3106.

https://doi.org/10.1182/blood.V78.11.3103.3103

Published: 1991

Journal Articles

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse

D Maraninchi, D Blaise, P Viens, M Brandely, D Olive, M Lopez, D Sainty, G Marit, AM Stoppa, J Reiffers

Blood (1991) 78 (9): 2182–2187.

https://doi.org/10.1182/blood.V78.9.2182.2182

Published: 1991

Journal Articles

Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation

D Blaise, D Olive, AM Stoppa, P Viens, C Pourreau, M Lopez, M Attal, C Jasmin, G Monges, C Mawas

Blood (1990) 76 (6): 1092–1097.

https://doi.org/10.1182/blood.V76.6.1092.1092

Published: 1990

Journal Articles

Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation

MF Bertheas, D Maraninchi, M Lafage, J Fraisse, D Blaise, AM Stoppa, G Michel, CP Brizard, MH Gaspard, G Novakovitch

Blood (1988) 72 (1): 89–93.

https://doi.org/10.1182/blood.V72.1.89.89

Published: 1988

NARROW

Autologous and Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome: A Large Series from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Cord Blood Transplantation after Non Myeloablative Conditioning (Minneapolis Protocol): Impact on Transplant Outcomes in 112 Adults with Hematologic Malignancy. A French Multicentric Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and Eurocord.

Donor Response to G-CSF Is the Best Predictive Factor of Extensive Chronic Graft-Versus-Host Disease after Non Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation.

Allogeneic Stem Cell Transplantation (SCT) with Non Myeloablative Conditioning Regimen (NST) Following Intensive Consolidation May Be Equivalent to Conventional alloSCT and Superior to autoSCT for Patients over 50 with Acute Myeloid Leukemia (AML) in 1 st CR: First Results of the AML 2001 Trial.

Fludarabine-Based HLA-Identical Sibling HSCT for Patients with Severe Aplastic Anemia (SAA) Older Than 30 Years: A Study from the French (SFGM-TC) and Italian (GITMO) Registries.

Stem Cell Transplantation in 281 Patients over 60 Years in Onco Hematologic Malignancies: A Single Center Experience.

Long Term Infectious Complications Following Reduced Intensity Conditioning (RIC)Allogeneic HLA-Identical Sibling Transplantation (allo-SCT).

Fludarabine and Busulfan-Based Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Transplantation (allo-SCT) with or without Anti-Thymocyte Globulin (ATG): Comparison between Two Prospective Studies in Patients with Myeloid Malignancies.

Karyotype in Acute Myeloblastic Leukemia: Prognostic Significance for Bone Marrow Transplantation in First Remission: A European Group for Blood and Marrow Transplantation Study

Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group

Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM)

Reconstitution of human immunoglobulin VH repertoire after bone marrow transplantation mimics B-cell ontogeny

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse

Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation

Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only